The particles were functionalized by cross-linking a VEGFR1-targeting peptide (SP5.2) and tTF to the particle surface and, together with an external magnetic field, demonstrated increased targeted tumor delivery relative to peptide-guided particles alone. This evidence concerns the gene FLT1 and neoplasm.